Carmentix’s CEO’s visit in BT Lab

Mr Nir Arbel, CEO of Carmentix, a company developing a novel biomarker prognostic panel for pre term birth set up a business meeting with BT Lab on Dec. 13th.

We had a discussion on current technical things on antibodies and cooperation of the ELISA and customized antibodies. Mr Arbel expressed his desire of working with us. BT Lab look fordward to his next tour in China and visit to BT Lab.

Leave a Comment

Your email address will not be published. Required fields are marked *